From: Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
Study group “TXA” (n=50) | Control group “placebo” (n=50) | P | |
---|---|---|---|
Hb. | |||
Preoperative | |||
Range | 10.1–13.7 | 10.1–13.9 | 0.466 |
Mean±SD | 12.63±0.82 | 12.18±1.08 | |
Postoperative | |||
Range | 9.5–12.8 | 8.3–12.1 | 0.024* |
Mean±SD | 11.66±0.79 | 10.53±1.07 | |
Reduction | |||
Mean±SD | 0.97±0.27 | 1.65±0.46 | <0.001** |
HCT | |||
Preoperative | |||
Range | 29.9–41.3 | 30.1–41.9 | 0.215 |
Mean±SD | 37.96±2.55 | 36.49±3.22 | |
Postoperative | |||
Range | 28.5–38.5 | 25–36.4 | <0.001** |
Mean±SD | 34.99±2.40 | 31.62±3.22 | |
Reduction | |||
Mean±SD | 2.97±0.83 | 4.87±1.36 | <0.001** |